Saturday, January 28, 2012

Johnson & Johnson Reports More Than $3 Billion in Quarterly Charges

Products Liability Attorneys Bolstering Efforts to Reach Out to DePuy Hip Implant Recipients in Response

Johnson & Johnson recently reported over $3 billion in quarterly charges. The charges come primarily as the result of legal settlements and other costs associated with products liability issues the company has had and continues to have with some of the devices in its DePuy line of hip replacement implants.

In August of 2010, Johnson & Johnson’s “DePuy Orthopedics” Division issued a voluntary recall of its Depuy ASR Hip Implant due to substandard failure rates. Specifically, the recall centered on DePuy’s ASR XL Acetabular Hip System and DePuy’s ASR Hip Resurfacing System. Recently however, the DePuy Pinnacle Hip Implant has also come under fire, but has not yet been recalled. The problem with the devices is the “metal on metal” design that the implants utilize, causing shards of metal and metal ions to enter patients’ bloodstreams, resulting in everything from dislocation to metallosis and even Chromium/Cobalt Blood Poisoning.

It is anticipated that this more than $3 billion in fourth-quarter charges will allow Johnson & Johnson to set aside monies for patients and attorneys who are involved in litigation against the company. In particular, the $3.3 billion in charges included $1.1 billion in pretax charges for litigation settlements related to the antipsychotic drug Risperdal, and approximately $1.5 billion in product-liability expenses stemming from surgeries and other procedures to repair defective DePuy ASR hip-replacement systems.

In light of these recent developments, select Products Liability Attorneys are bolstering efforts to reach out to DePuy ASR and DePuy Pinnacle Hip Implant Recipients, ramping up their online presence in an effort to get its message across to the numerous DePuy Hip Implant Recipients it believes have yet to seek advice on their individual situation.

The particular concern centers on making sure that any ASR or Pinnacle Implant Recipients are aware of their rights. These Attorneys want these Implant Recipients to know that the law limits the amount of time that individuals have to file claims. Moreover, they also anticipate that the closure of the Multi-District Litigation is on the horizon, and unfortunately, claims litigated after this event may be more difficult to settle.

Author: Sullo & Sullo Attorneys

0 Comments

Categories: ImportedNumber of views: 1483

Tags: $3 billion Johnson & Johnson Products Liability Attorneys

Please login or register to post comments.

250,000 CLIENTS REPRESENTED

FREE CASE REVIEW

Full Name* Email* Telephone Number* Are You already a Client?* Type of Case* Tell Us About Your Case*

WARNING: Do not send any information in any email through this website if you consider the information confidential or privileged.

I understand that by submitting my contact information to Sullo & Sullo LLP for review, I consent to messages regarding this legal matter as well as marketing for other potential legal matters in the future without limitation at standard messaging and data rates unless terminated by me in writing. I further understand that my submission of any and all information in response to this website does NOT create a lawyer-client relationship between myself and Sullo & Sullo, LLP and/or its lawyers, and that any and all information submitted is NOT confidential or privileged. I further acknowledge that, unless Sullo & Sullo, LLP subsequently enters into an Attorney-Client relationship with me, any and all information I provide will NOT be treated as confidential or privileged, and any such information may be used against me and/or for the benefit of current or future clients of Sullo & Sullo, LLP. ...READ ENTIRE DISCLAIMER

Receive an Immediate Response

ANDREW SULLO IS A TOP 100 NATIONAL TRIAL LAWYER 2013 • 2014 • 2015 • 2016 • 2017 • 2018 • 2019

Obtener una Respuesta Inmediata

Andrew Sullo – 100 Mejores Abogados Nacional | 2013 • 2014 • 2015 • 2016 • 2017